Efficacy of 25% diluted fluticasone propionate 0.05% cream as wet-wrap treatment in cutaneous mastocytosis

被引:9
作者
Heide, Rogier
de Waard-van der Spek, Flora B.
den Hollander, Jan C.
Tank, Bhupendra
Oranje, Arnold P.
机构
[1] MCA, Dept Dermatol, Alkmaar, Netherlands
[2] Erasmus MC, Dept Dermatol & Venerol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Clin Pathol, Rotterdam, Netherlands
关键词
mastocytosis; fluticasone propionate 25% diluted; wet-wrap;
D O I
10.1159/000100885
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Mastocytosis is a disorder that can be subdivided into two forms: cutaneous and systemic. Patients with cutaneous mastocytosis only may suffer from cosmetic problems. Topical steroid application has been shown to be effective in cases of limited skin lesions. Methods: A case-controlled pilot study was conducted during a 6-weeks treatment using diluted 25% fluticasone propionate 0.05% cream under wet-wrap occlusion in 5 adults and 6 children. Improvement was measured up to the 24th week after treatment using the SCORMA Index. Results: The results of this pilot study showed a partial but clear cosmetic improvement in 9 of the 11 patients. The mean SCORMA Index decreased after treatment from 38 to 26. Conclusion: 25% dilution of fluticasone propionate 0.05% cream under wet-wrap occlusion is an alternative treatment modality for alleviating the symptoms of cutaneous mastocytosis, but the improvement may be moderate and fall short of the patient's expectations. Copyright (c) 2007 S. Karger AG, Basel
引用
收藏
页码:333 / 335
页数:3
相关论文
共 13 条
[1]   Efficacy and safety of 'wet-wrap' dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature [J].
Devillers, ACA ;
Oranje, AP .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (04) :579-585
[2]   Treatment of refractory atopic dermatitis using 'wet-wrap' dressings and diluted corticosteroids: Results of standardized treatment in both children and adults [J].
Devillers, ACA ;
de Waard-van der Spek, FB ;
Mulder, PGH ;
Oranje, AP .
DERMATOLOGY, 2002, 204 (01) :50-55
[3]   Mastocytosis: current concepts in diagnosis and treatment [J].
Escribano, L ;
Akin, C ;
Castells, M ;
Orfao, A ;
Metcalfe, DD .
ANNALS OF HEMATOLOGY, 2002, 81 (12) :677-690
[4]   Efficacy of crisis intervention treatment with topical corticosteroid prednicarbat with and without partial wet-wrap dressing in atopic dermatitis [J].
Foelster-Holst, R ;
Nagel, F ;
Zoellner, P ;
Spaeth, D .
DERMATOLOGY, 2006, 212 (01) :66-69
[5]   Mastocytosis in childhood [J].
Heide, R ;
Tank, B ;
Oranje, AP .
PEDIATRIC DERMATOLOGY, 2002, 19 (05) :375-381
[6]   Clinical scoring of cutaneous mastocytosis [J].
Heide, R ;
Hup, MAM ;
Mulder, PGH ;
Oranje, AP .
ACTA DERMATO-VENEREOLOGICA, 2001, 81 (04) :273-276
[7]   UBER DIE SELEKTIVE FERMENTCYTOCHEMISCHE DARSTELLUNG VON NEUTROPHILEN MYELOISCHEN ZELLEN + GEWEBSMASTZELLEN IM PARAFFINSCHNITT [J].
LEDER, LD .
KLINISCHE WOCHENSCHRIFT, 1964, 42 (11) :553-&
[8]  
Mateo JR, 2001, J EUR ACAD DERMATOL, V15, P492
[9]   Treatment of erythrodermic atopic dermatitis with "wet-wrap" fluticasone propionate 0.05% cream/emollient 1:1 dressings [J].
Oranje, AP ;
Wolkerstorfer, A ;
de Waard-van der Spek, FB .
JOURNAL OF DERMATOLOGICAL TREATMENT, 1999, 10 (01) :73-74
[10]  
Tharp Michael D, 2003, Adv Dermatol, V19, P207